Plasticell and GSK sign collaboration agreement
Contains production of hematopoietic cells from iPSCs
18-Oct-2017 -
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) ...
biotechnology
collaborations
gene therapy
+5